Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung c...

por Krzakowski, M., Bennouna, J., Dansin, E., Kowalski, D., Hiret, S., Penel, N., Favrel, S., Tourani, J. M.
Publicado 2013

QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization

por Keirns, J, Desai, A, Kowalski, D, Lademacher, C, Mujais, S, Parker, B, Schneidkraut, MJ, Townsend, R, Wojtkowski, T, Yamazaki, T, Yen, M, Kowey, PR
Publicado 2017

Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients wit...

por Le Gall-Ianotto, C., Verdet, R., Nowak, E., Le Roux, L., Gasse, A., Fiedler, A., Carlhant-Kowalski, D., Marcorelles, P., Misery, L., Ianotto, J. C.
Publicado 2021

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lun...

por Camerini, A., Morabito, A., Montanino, A., Bernabé, R., Grossi, F., Ramlau, R., Ciuleanu, T.-E., Ceresoli, G.-L., Pasello, G., de Marinis, F., Bosch-Barrera, J., Laundreau, P., Gautier, S., Ta Thanh Minh, C., Kowalski, D.
Publicado 2021